Orthopedic Footwear Market Analysis

  • Report ID: 2508
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Orthopedic Footwear Market Segmentation:

Product Segment Analysis

The shoes segment is estimated to hold 45% share of the global orthopedic footwear market by the end of 2035. Orthopedic shoes are used to provide support to flat feet. In addition, there are numerous benefits of orthopedic shoes such as shock absorption, stability, and high ability to walk as well as distributing weight evenly, this segment is predicted to grow in the market during the forecasted period.

Indication Segment Analysis

The diabetes & edema segment in the orthopedic footwear market is set to garner the highest gain in the upcoming years with 47%. This segment is said to be increasing the market growth owing to the rising cases of diabetes worldwide as diabetes results in swollen feet. According to the International Diabetes Federation, around 700 million people are predicted to suffer from diabetes by 2045.  Moreover, an increase in the number of diabetic patients in developing countries anticipates the demand for orthopedic footwear and diabetic footwear across the globe. The bulk of the approximately 422 million individuals with diabetes globally reside in low- and middle-income nations, and diabetes is directly responsible for 1.5 million fatalities annually.

Our in-depth analysis of the global orthopedic footwear market includes the following segments:

           Product

  • Slippers
  • Sandals
  • Shoes

           End User

  • Children <5 years
  • Juveniles
  • Girls
  • Boys
  • Adults
  • Women
  • Men

            Distribution Channel

  • Stores Based
  • Online Stores

             Indication

  • Diabetes & Edema
  • Arthritis
  • Flat Feet
  • Heel Pain

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of orthopedic footwear is estimated at USD 5.58 billion.

The global orthopedic footwear market size was worth more than USD 5.11 billion in 2025 and is poised to witness a CAGR of over 10.2%, crossing USD 13.5 billion revenue by 2035.

By 2035, the shoes segment in the orthopedic footwear market is expected to account for a 45% share, propelled by benefits such as enhanced stability, shock absorption, and improved weight distribution supporting flat-footed individuals.

Key players in the market include Darco, Dr. Comfort, Mephisto, Apex, Propet, Vionic, Chaneco, Duna, Orthofeet Inc., Piedro.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos